A NEW ANGLE Discovery of a Mutation in a Rare Pediatric Brain Tumor Gives Researchers New Targets to Go After for a Cure Submit Your Next Paper to an ASBMB Journal!

Total Page:16

File Type:pdf, Size:1020Kb

A NEW ANGLE Discovery of a Mutation in a Rare Pediatric Brain Tumor Gives Researchers New Targets to Go After for a Cure Submit Your Next Paper to an ASBMB Journal! Vol. 14 / No. 6 / June/July 2015 A NEW ANGLE Discovery of a mutation in a rare pediatric brain tumor gives researchers new targets to go after for a cure Submit Your Next Paper to an ASBMB Journal! When you submit a paper to an ASBMB ASBMB journal special features: journal, you can expect: • Customized eTOC alerts • Thorough, constructive reviews by scientists • Explore the Editorial Board • Affordable publication charges (*FREE color) • Meet new Associate Editors • Peer reviewed papers published the day of • Read Collections including: Reflections, acceptance Minireviews and Thematic Series *ASBMB has eliminated color figure fees for Regular ASBMB www.asbmb.org/publications members publishing as corresponding authors. CONTENTS NEWS FEATURES PERSPECTIVES 2 18 29 PRESIDENT’S MESSAGE A NEW ANGLE GENERATIONS The straight-jacket 29 Temptation of hypothesis-driven research 24 30 The truth goes only so far MEET SVETLANA LUTSENKO 5 32 NEWS FROM THE HILL 27 HOBBIES Young scientists advocate Something is fishy in the dean’s office! for research funding on the Hill DEFYING STEREOTYPES “So, a biochemist walks 6 into a comedy club …” 33 MEMBER UPDATE EDUCATION 18 33 Playing games to learn Chief science 35 Empty bench syndrome 7 correspondent Rajendrani RETROSPECTIVE Mukhopadhyay reports on an important advance 36 Richard Nelson Perham in the study of a pediatric OPEN CHANNELS (1937 − 2015) brain cancer that has always been unbeatable. 8 29 LIPID NEWS Development of lipids and lipid 16 analogues as potential drugs 11 TOOLKIT All about ELISA 32 12 NEWS 12 Let’s talk about aphasia 27 13 JOURNAL NEWS 13 A look at the Tat system 14 Study outlines how inadequate vitamin E can cause brain damage 15 The promise of personalized nutrition 16 An unexpected finding in prehistoric bison bones JUNE/JULY 2015 ASBMB TODAY 1 PRESIDENT’S MESSAGE THE MEMBER MAGAZINE OF THE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY The straight-jacket OFFICERS COUNCIL MEMBERS Steven McKnight Natalie Ahn of hypothesis-driven President Squire J. Booker Karen G. Fleming Jeremy M. Berg Gregory Gatto Jr. Past President Daniel Leahy Anjana Rao research Karen Allen Secretary Jared Rutter Brenda Schulman By Steven McKnight Toni Antalis Michael Summers Treasurer ASBMB TODAY EDITORIAL EX-OFFICIO MEMBERS ADVISORY BOARD he advancement of biomedical this latter kind of research follows the Dorothy Beckett Charles Brenner research requires both leaps of concepts of inductive inquiry (I2). Mary Roberts Chair discovery and the steady progress Central to the utility of the I2 form Co-chairs, 2015 Annual Michael Bradley T Meeting Program Floyd “Ski” Chilton that separates one leap from another. of biomedical research is the defini- Committee Cristy Gelling Leaps are universally unanticipated; tion of a phenomenon. Here is an Peter J. Kennelly Peter J. Kennelly no one ever wrote them as specific example of a phenomenon of interest. Chair, Education and Rajini Rao Professional Development Yolanda Sanchez aims in National Institutes of Health During hibernation, the core body Committee Shiladitya Sengupta grant applications. Gradual transitions temperature of ground squirrels goes Daniel Raben Carol Shoulders are the opposite. They are the essence from 37°C down to 4 – 5°C. Perplex- Chair, Meetings Committee ASBMB TODAY of what we write as the specific aims ingly, with robust periodicity, hiber- Takita Felder Sumter of our grant proposals. Gradual transi- nating ground squirrels warm back up Chair, Minority Affairs Angela Hopp Committee Executive Editor, tions fit hand-in-glove with hypothe- to 37°C around once every 10 days [email protected] Thomas Baldwin sis-driven research. (2). These brief periods of warming Lauren Dockett Chair, Outreach Committee Managing Editor, I lament that, as presently con- are called interbout arousals. What is Bob Matthews [email protected] structed, the NIH system of funding the utility to the hibernating ground Chair, Public Affairs Rajendrani Mukhopadhyay science is locked into the straight- squirrel to periodically warm up for Advisory Committee Chief Science Correspondent, jacket of hypothesis-driven research. about a day? Kathleen Collins [email protected] Chair, Publications Valery Masterson It is understandable that things have To me, this is a cool phenom- Committee Designer, evolved in this manner. In times of enon. Interbout arousals are almost [email protected] Martha J. Fedor Lauri Pantos tight funding, grant reviewers find it perfectly periodic, and they entail Editor-in-chief, JBC Manager of Publications easier to evaluate hypothesis-driven re- profound changes in body tem- Herbert Tabor Technology, [email protected] search plans than blue-sky proposals. perature. Instincts tell me something Co-editor, JBC Ciarán Finn The manner in which the system has quite important is taking place when A. L. Burlingame Web Publication Assistant, Editor, MCP [email protected] evolved has forced scientists to per- hibernating animals warm up briefly Barbara Gordon Edward A. Dennis form contractlike research that grant like clockwork. As cool as this science Executive Director, Joseph L. Witztum [email protected] reviewers judge to be highly likely to is, it is hard to distill it down to a set Co-editors, JLR Allison Frick succeed. In financially difficult times, of measurable, specific aims. Sure, Media Specialist, more risky scientific endeavors with one can say that it would be useful [email protected] no safely charted pathway to success to do some cataloging — measuring For information on advertising, contact Pharmaceutical often get squeezed out. metabolite fluctuation as a function of Media Inc. at 212-904-0374 or [email protected]. We all recognize the formula and hibernation and entry and exit from nature of hypothesis-driven research; interbout arousals. Sure, one might we describe it over and over in the hope then to garner some clues that thousands of grant applications we might lead the way out of the woods www.asbmb.org/asbmbtoday PRINT ISSN 2372-0409 write and submit for review by the But it is hard to say exactly how the Articles published in ASBMB Today reflect solely NIH each year. But how should we science would unfold in the context of the authors’ views and not the official positions of describe the riskier blue-sky research the hypothesis-driven form of research the American Society for Biochemistry and Molecular Biology or the institutions with which the authors that our granting agencies tend not to we are now forced to perform. As are affiliated. Mentions of products or services are favor? I have written about this topic nebulous as it might seem, my predic- not endorsements. before (1), and I have suggested that ©2015 ASBMB 2 ASBMB TODAY JUNE/JULY 2015 tion is that a talented and dedicated ES cells divide more rapidly than any is neuron death enacted? scientist would have a good chance of cancer cell – almost as fast as micro- I can think of hypotheses with making cool discoveries if offered the bial organisms, such as yeast. Why do which to begin investigation of these chance to pursue this research for the ES cells divide so rapidly, and how is phenomena, but most such hypoth- duration of a typical R01 grant from hypermitotic drive facilitated? I also eses would be highly biased owing to the NIH. find it fascinating that prototrophic the extreme limitations of my knowl- Were it up to me, and it is clearly strains of yeast (AKA wild type, native edge of ES cell growth, yeast metabo- not, I would demand that NIH grant or nondomesticated), when grown lism or hippocampal neurogenesis. applications start with the descrip- under nutrient-limiting conditions in This being the case, it would be folly tion of a unique phenomenon. When a chemostat, enter into an incredibly to submit NIH grant applications in I say unique, I mean unique to the robust and periodic metabolic cycle. search of funding to support research applicant. The phenomenon may have What is the physiologic utility of on these topics. As mentioned above, come from the prior research of the this metabolic cycle, and what is the it is not up to me to guide the NIH applicant. Alternatively, the phenom- underlying regulatory logic control- on how to spend its funds. On the enon may have come from the ap- ling it? Finally, the vast majority of other hand, we live in a country that plicant’s unique observation of nature, newly formed neurons born daily is highly protective of freedom of medicine or the expansive literature. in the adult mouse brain die along speech. With that in mind, I happily Phenomena abound. One of the pathway toward differentiation offer the thesis outlined in this essay several that have intrigued me over and ultimate wiring into the central and close with Albert Einstein’s iconic the past decade is the speed of mouse nervous system. Why do so many of quote: “If we knew what we are doing, embryonic cell duplication. Mouse the cells die, and by what mechanism it would not be called research.” Steven McKnight (steven. REFERENCES [email protected]) 1. McKnight, S.L. Cell 138, 817 - 819 (2009). is president of the American 2. Carey, H.V. et al. Physiol. Rev. 4, 1153 - 1181 (2003). Society for Biochemistry and Molecular Biology and chairman of the biochemistry department at the University of Texas-Southwestern Medical Center at Dallas. JUNE/JULY 2015 ASBMB TODAY 3 SAVE the DATE Over 26% of attendees in 2014 made a scheduled spoken presentation. Submit an abstract by August 4 to be considered for a speaking spot: • Minisymposium Standard Talk (15-minute talk, 5-minute Q&A) • Minisymposium Lightning Talk (5 minute talk, 1-2-minute Q&A) • Microsymposium Talk (5-minute talks with electronic posters) The meeting’s arc will follow the integration of cell biology across diverse fields, scales, and structures into newly relevant scientific disciplines.
Recommended publications
  • Quantum Biology: an Update and Perspective
    quantum reports Review Quantum Biology: An Update and Perspective Youngchan Kim 1,2,3 , Federico Bertagna 1,4, Edeline M. D’Souza 1,2, Derren J. Heyes 5 , Linus O. Johannissen 5 , Eveliny T. Nery 1,2 , Antonio Pantelias 1,2 , Alejandro Sanchez-Pedreño Jimenez 1,2 , Louie Slocombe 1,6 , Michael G. Spencer 1,3 , Jim Al-Khalili 1,6 , Gregory S. Engel 7 , Sam Hay 5 , Suzanne M. Hingley-Wilson 2, Kamalan Jeevaratnam 4, Alex R. Jones 8 , Daniel R. Kattnig 9 , Rebecca Lewis 4 , Marco Sacchi 10 , Nigel S. Scrutton 5 , S. Ravi P. Silva 3 and Johnjoe McFadden 1,2,* 1 Leverhulme Quantum Biology Doctoral Training Centre, University of Surrey, Guildford GU2 7XH, UK; [email protected] (Y.K.); [email protected] (F.B.); e.d’[email protected] (E.M.D.); [email protected] (E.T.N.); [email protected] (A.P.); [email protected] (A.S.-P.J.); [email protected] (L.S.); [email protected] (M.G.S.); [email protected] (J.A.-K.) 2 Department of Microbial and Cellular Sciences, School of Bioscience and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK; [email protected] 3 Advanced Technology Institute, University of Surrey, Guildford GU2 7XH, UK; [email protected] 4 School of Veterinary Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK; [email protected] (K.J.); [email protected] (R.L.) 5 Manchester Institute of Biotechnology, Department of Chemistry, The University of Manchester,
    [Show full text]
  • Catalysishub NEWSLETTER
    CatalysisHub NEWSLETTER The UK Catalysis Hub has created a thriving and successful network of catalytic scientists who are developing and promoting catalytic science in the UK. The Hub has succeeded in coordinating the community and is contributing to the development of new approaches and techniques in the field. It has provided substantial added value and is now recognised widely both in the UK and internationally. It will provide an excellent base for the future development of this crucial area of science in the UK. “The Hub has demonstrated resilience in the current pandemic with the community coming together to support each other through webinars and training courses and we will continue these in more normal times. Our proposal round was very successful with a large number of high quality proposals submitted and we have funded an excellent portfolio of research. The next few months will hopefully see an easing of the lockdown and an increase in our ability to do research. We hope that all are keeping well and safe and we look forward to meeting in person when we can and discussing catalytic research face to face.” ~ Professor Christopher Hardacre, Director Events Highlights of 2020 online via our website, so they will be a future resource for the whole catalysis community. COVID-19 has had a major impact on scientific network and dissemination due to travel UKCC 2020, 7 - 9 January 2020 restrictions and social distancing making face to face meetings and conferences unfeasible. The UK Catalysis Hub winter conference was held virtually and we worked on a vibrant programme of webinars, scientific discussions and other online events.
    [Show full text]
  • Revised January 2003
    Revised 9 June 2017 CURRICULUM VITAE NAME Anjana Rao OFFICE ADDRESS La Jolla Institute for Allergy & Immunology 9420 Athena Circle La Jolla, CA 92037 Telephone: (858) 952-7155/7161 FAX: (858) 752-6984 Email: [email protected] PLACE OF BIRTH Washington, D. C., USA EDUCATION 1970 B.Sc. Osmania University, Hyderabad, India 1972 M.Sc. Osmania University, Hyderabad, India (Physics) 1978 Ph.D. Harvard University, Cambridge, MA (Biophysics) POSTDOCTORAL TRAINING 1978-1979 Fellow in Medicine, Harvard Medical School 1979-1981 Fellow in Pathology, Harvard Medical School ACADEMIC APPOINTMENTS 1981-1984 Instructor in Pathology, Harvard Medical School 1984-1992 Assistant Professor of Pathology, Harvard Medical School 1993-1995 Associate Professor of Pathology, Harvard Medical School 1981-2009 Board of Tutors, Department of Biochemistry and Molecular Biology, Harvard University 1988-1995 Associate Head Tutor, Department of Biochemistry and Molecular Biology, Harvard University 1996-2010 Professor of Pathology, Harvard Medical School 1995-2011 Senior Investigator, Immune Disease Institute 2009-2011 Program in Cellular and Molecular Medicine, Children’s Hospital Boston 2010-present Professor, Division of Signaling and Gene Expression, La Jolla Institute (LJI) 2011-present Professor, Sanford Consortium for Regenerative Medicine, La Jolla 2011-present Affiliate faculty appointment, Department of Pharmacology, UCSD 2011-present Faculty member, Biomedical Sciences Graduate Program, UCSD 2011-present Health Sciences Immunity/Infection/Inflammation (Triple I), UCSD
    [Show full text]
  • Synthetic Biology
    From Molecular Biology to Synthetic Biology, what’s new? Sandra Taylor, Senior Research Technician, BSc (Hons), Mphil, Rsci, MIScT [email protected] (0161) 306 5131 Small beginnings in Norwich, after my first degree • 1987 - First lab job veterinary tests: Bacteriology, post mortems, blood, urine, faeces tests etc. Plant Molecular Genetics 1988 to 1998 – the lab grew from 6 to 16 people and several papers were published on the way that flowering is controlled. 1998 to 2001: Biochemistry Division, School of Biological Sciences, Manchester University – I supported 6 research groups, sharing expertise. Topics from cell division (in toads) to asthma (in horses and people), and cultured human cells. Career Break from 2001 to 2007 • Starting again after 6 years was a challenge but I soon got back up to speed. Technical roles are very varied, never boring, a bit like being a Mum! 2007 to present • I spent 7 years in the Michael Smith Building (Life Sciences) – various roles (cell culture, cloning, yeast two-hybrid) • In 2014 I moved to the MIB – more Chemistry/Biochemistry focussed Nano-scale 3D printing?! Micro-titre plates with 96, 384 or even 1536 sample wells – technology is being developed to “write” strings of DNA into these tiny wells using 3D nano-printing technology. Present Challenges Supporting SYNBIOCHEM • New subject(s) and equipment to learn about • The new SYMBIOCHEM team is 10 people and 4 robots! • IT technology means writing electronic lab notebooks instead of paper ones! • The new team is multidisciplinary so lots to learn but good fun! • This is now the age of writing DNA, as opposed to just reading it Publications (please note publications I contributed prior to 2006 were under my maiden name of Doyle) Structural Basis for Specific Interaction of TGFβ Signaling Regulators SARA/Endofin with HD-PTP.
    [Show full text]
  • Scientists a Step Closer to Developing Renewable Propane 10 April 2015
    Scientists a step closer to developing renewable propane 10 April 2015 change. Efforts to find cleaner, more sustainable forms of energy as well as using biotechnology techniques to produce synthetic chemicals are currently being developed at The University of Manchester." Natural metabolic pathways for the renewable biosynthesis of propane do not exist but scientists at the University have developed an alternative microbial biosynthetic pathway to produce renewable propane. The team led by Nigel Scrutton and Dr Patrik Jones from Imperial College, modified existing fermentative butanol pathways using an engineered enzyme variant to redirect the microbial pathway to produce propane as opposed to butanol. The team was able to achieve propane biosynthesis creating a platform for next-generation microbial propane production. Researchers at The University of Manchester have Propane has very good physicochemical properties made a significant breakthrough in the which allow it to be stored and transported in a development of synthetic pathways that will enable compressed liquid form. While under ambient renewable biosynthesis of the gas propane. This conditions it is a clean-burning gas, with existing research is part of a programme of work aimed at global markets and infrastructure for storage, developing the next generation of biofuels. distribution and utilization in a wide range of applications ranging from heating to transport fuel. This study provides new insight and understanding Consequently, propane is an attractive target of the development of next-generation biofuels. In product in research aimed at developing new this latest study, published in the journal renewable alternatives to complement currently Biotechnology for Biofuels, scientists at the used petroleum-derived fuels.
    [Show full text]
  • Proteins: from Chemical to Physiological Mechanism 26 October 2001
    Meeting report report Proteins: from Chemical to Physiological Mechanism 26 October 2001 The Molecular Enzymology Group of the Biochemical Society by David Trentham held a special 1-day meeting at the Royal Society on ‘Proteins: (National Institute of Medical from Chemical to Physiological Mechanism’.The aim of the Research, Mill Hill) and Downloaded from http://portlandpress.com/biochemist/article-pdf/24/3/31/3597/bio024030031.pdf by guest on 01 October 2021 meeting was to inform and stimulate discussion on kinetic Michael Greeves approaches to the life sciences by bringing together work on (University of Kent) dynamic aspects of protein function.The meeting also honoured Professor H. (Freddie) Gutfreund, FRS, on his 80th birthday. Professor Gutfreund persuaded the Executive Committee of the Society to found the Molecular Enzymology Group, the first sub-group of the Society. His view of the strategic value in Professor Freddie encouraging like-minded biochemists to interact has done much to Gutfreund during his provide the critical mass necessary for sustaining excellence in the presentation ‘Development various sub-disciplines of biochemistry. of kinetics in biology’. The talks reflected Professor about how proteins function. and his family. The dinner was Gutfreund’s many contributions In particular, he has made major followed by entertaining and to the study of biochemistry and contributions to the development affectionate talks presented biophysics. His early prominence of transient and relaxation kinetic by Nigel Scrutton, the present arose from developing the method- methods including stopped-flow, Chairman of the Molecular Speakers and Chairmen: ology to study fast events on quenched-flow and pressure- Enzymology Group, Hugh Back row (from left to enzymes which are now central to jump techniques.
    [Show full text]
  • Computational Protein (Re)Design (Computationele Eiwit(Her)Engineering)
    Faculty of Science and Engineering Profile report: Computational Protein (Re)design (Computationele eiwit(her)engineering) - Discipline: Chemistry - Level: Assistant or Associate Professor - Fte: Full time (1.0) 1. Scientific discipline The professor in Computational Protein (Re)Design integrates advances in computer sciences with clever experimental concepts to redesign biological macromolecules towards new or altered functionalities. The envisioned research group uses computer sciences (computational design, multiscale modeling, machine learning) and combines this with existing expertise in biochemistry (enzymology, protein engineering, drug design) to further our understanding of the molecular processes of life and to expand the potential of enzymes and other biomolecules for biotechnological or biomedical purposes. 2. Vacancy This position is offered at the Faculty of Science and Engineering (FSE) of the University of Groningen and will be embedded in the Groningen Biomolecular Sciences and Biotechnology Institute (GBB). The GBB institute has 12 vibrant research groups, targeting challenging biological questions in the focal areas ‘Molecular Mechanisms of Biological Processes’ and ‘Physiology and Systems Biology’. The position has been approved by the Faculty board, is part of the Dutch Sector Plans in Chemistry, and falls within the framework of ‘Career Paths in Science 4’ (‘Bèta’s in Banen 4’). 3. Selection committee - Prof. Bert Poolman (Professor in biochemistry), chair - Prof. Marco Fraaije (Professor in molecular enzymology) - Prof. Siewert Jan Marrink (Professor in molecular dynamics) - Prof. Shirin Faraji (Adjunct Professor in theoretical and computational chemistry) - Prof. Marleen Kamperman (Professor in polymer chemistry) - Prof. Dirk-Jan Scheffers (Director of Education, GBB) - Prof. Nigel Scrutton (Professor in Biological Chemistry, University of Manchester) - Mrs. Gwen Tjallinks (Student member) Additional (external) advisors: - Prof.
    [Show full text]
  • System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes
    System-wide modulation of HECT E3 ligases with selective ubiquitin variant probes Wei Zhang1,11, Kuen-Phon Wu2,11, Maria A. Sartori1, Hari B. Kamadurai2, Alban Ordureau3, Chong Jiang4, Peter Y. Mercredi2, Ryan Murchie4, Jicheng Hu5, Avinash Persaud4, Manjeet Mukherjee2, Nan Li6, Anne Doye7, John R. Walker5, Yi Sheng8, Zhenyue Hao9, Yanjun Li5, Kevin R. Brown1, Emmanuel Lemichez7, Junjie Chen6, Yufeng Tong5,10, J. Wade Harper3, Jason Moffat1,12, Daniela Rotin4,12, Brenda A. Schulman2,12 * and Sachdev. S. Sidhu1,12 * 1Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, 160 College Street, Toronto, Ontario M5S3E1, Canada 2Department of Structural Biology and Tumor Cell Biology, Howard Hughes Medical Institute, St. Jude Children's Research Hospital, Memphis, TN 38105, USA 3Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA 4Program in Cell Biology, Hospital for Sick Children, and Department of Biochemistry, University of Toronto, Toronto, Ontario M5G 0A4, Canada 5Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G1L7, Canada 6Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA 7Inserm U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Université de Nice-Sophia Antipolis, 151 Route St Antoine de Ginestière, BP 2 3194, 06204 Nice Cedex, France. 8Department of Biology, York University, Toronto, Ontario M3J1P3, Canada 9Campbell Family Cancer Research Institute, University Health Network, Toronto, Ontario M5G2C1, Canada 10Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5G1L7, Canada 11Co-first author 12Co-senior author *To whom correspondence should be addressed. E-mail: [email protected] (B.A.S.) and [email protected] (S.S.S).
    [Show full text]
  • NR4A Transcription Factors Limit CAR T Cell Function in Solid Tumors
    LETTER https://doi.org/10.1038/s41586-019-0985-x NR4A transcription factors limit CAR T cell function in solid tumours Joyce Chen1,2,3,4*, Isaac F. López-Moyado1,4,5, Hyungseok Seo1, Chan-Wang J. Lio1, Laura J. Hempleman1, Takashi Sekiya6, Akihiko Yoshimura7, James P. Scott-Browne1,4,9,10* & Anjana Rao1,3,4,8,10* T cells expressing chimeric antigen receptors (CAR T cells) targeting CD8+CD45.1+ OT-I cells (specific for chicken ovalbumin (OVA) human CD19 (hCD19) have shown clinical efficacy against B cell SIINFEKL peptide presented by H-2Kb; Extended Data Fig. 2a, b) malignancies1,2. CAR T cells have been less effective against solid showed similar tumour growth rates (Extended Data Fig. 2c); low tumours3–5, in part because they enter a hyporesponsive (‘exhausted’ numbers of CAR T cells were transferred to minimize tumour rejec- or ‘dysfunctional’) state6–9 triggered by chronic antigen stimulation tion (Extended Data Fig. 2d). Eight days after adoptive transfer, CAR and characterized by upregulation of inhibitory receptors and loss of and OT-I tumour-infiltrating lymphocytes (TILs) (Fig. 1b, Extended effector function. To investigate the function of CAR T cells in solid Data Fig. 2b, e, f) comprised around 18% and 9%, respectively, of CD8+ tumours, we transferred hCD19-reactive CAR T cells into hCD19+ TILs (Fig. 1c) and exhibited similar proportions of PD-1hiTIM3hi cells tumour-bearing mice. CD8+CAR+ tumour-infiltrating lymphocytes compared to endogenous TILs (Fig. 1b, Extended Data Fig. 2b). All and CD8+ endogenous tumour-infiltrating lymphocytes expressing TILs produced low levels of TNF and IFNγ upon re-stimulation with the inhibitory receptors PD-1 and TIM3 exhibited similar profiles PMA and ionomycin (Fig.
    [Show full text]
  • Tet2 and Tet3 Cooperate with B-Lineage Transcription Factors To
    RESEARCH ARTICLE Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility Chan-Wang Lio1†, Jiayuan Zhang2†, Edahı´Gonza´ lez-Avalos1, Patrick G Hogan1, Xing Chang1,2,3*, Anjana Rao1,3,4,5* 1Division of Signaling and Gene Expression, San Diego, United States; 2Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Shanghai Jiao Tong University School of Medicine, Shanghai, China; 3Sanford Consortium for Regenerative Medicine, San Diego, United States; 4Department of Pharmacology, University of California, San Diego, San Diego, United States; 5Moores Cancer Center, University of California, San Diego, San Diego, United States Abstract Ten-eleven translocation (TET) enzymes oxidize 5-methylcytosine, facilitating DNA demethylation and generating new epigenetic marks. Here we show that concomitant loss of Tet2 and Tet3 in mice at early B cell stage blocked the pro- to pre-B cell transition in the bone marrow, decreased Irf4 expression and impaired the germline transcription and rearrangement of the Igk locus. Tet2/3-deficient pro-B cells showed increased CpG methylation at the Igk 3’ and distal enhancers that was mimicked by depletion of E2A or PU.1, as well as a global decrease in chromatin accessibility at enhancers. Importantly, re-expression of the Tet2 catalytic domain in *For correspondence: Tet2/3-deficient B cells resulted in demethylation of the Igk enhancers and restored their chromatin [email protected] (XC); arao@ accessibility. Our data suggest that TET proteins and lineage-specific transcription factors lji.org (AR) cooperate to influence chromatin accessibility and Igk enhancer function by modulating the modification status of DNA.
    [Show full text]
  • Press Release, February 12, 2020 in the Right Place at the Right Time
    public relations Press Release, February 12, 2020 dr. christiane menzfeld phone: +49 89 8578-2824 [email protected] www.biochem.mpg.de/news @MPI_Biochem In the right place at the right time Scientists at the Max Planck Institute of Biochemistry (MPIB) decipher the activation chain of protein degradation Proteins are molecular work horses in the cell that perform specific tasks, but it is essential that the timing of protein activities is exquisitely controlled. When proteins have fulfilled their tasks, degradation of these proteins will end processes that are unneeded or detrimental. To control timing, a label – called “ubiquitin” - is attached to unwanted proteins, marking the protein for degradation. Although complex molecular machineries were known to attach ubiquitin, how these machines carry out the labeling process was unknown. Researchers at MPIB, in collaboration with the University of Nevada Las Vegas, have revealed these mechanisms and published the results in the journal Nature. Numerous cellular processes such as immune responses or cell multiplication depend on many different proteins working in sequence. In order for the cell to function correctly, proteins must be degraded after their work is done. When disease-causing mutations block timely protein degradation, proteins could function at the wrong time, which can lead to diseases, including cancers, heart diseases and developmental disorders. Controlling protein degradation Cells “know” to break down proteins by marking unwanted proteins for degradation with another protein called "ubiquitin". The labelling process, known as ubiquitylation, is carried out by molecular machines, called E3 ligases. It is important that the E3 ligases themselves are switched on and off in the cells at the right place and at the right time.
    [Show full text]
  • Prof. Dr. Brenda Schulman Ft
    Research Interests – Prof. Dr. Brenda Schulman Ft Proteins are the workhorses of cells. Some proteins play structural roles, for example serving as architectural frameworks underlying cell shape; other proteins are enzymes that synthe- sise and break down sugars, fats, and other types of molecules needed for cellular metabo- lism; some proteins have motor domains to achieve movement, for example untangling com- plicated macromolecular assemblies or transporting cargoes to precise locations within cells. The staggering array of protein functions vastly exceeds the number of different proteins en- coded by an organism’s genome (e.g., roughly 20,000 different proteins can be made from scratch in human cells). To meet cellular demands and establish regulation, the structures and functions of pre-existing proteins can be transformed in innumerable ways by post-trans- lational modification. A predominant set of modifications involves covalent linkage of ubiquitin (UB) and members of the family of ubiquitin-like proteins (UBL). We study molecular princi- ples, cellular pathways, and biological roles of regulation by UB and UBL. This is of broad im- portance for understanding numerous biological processes, and for deciphering signalling pathways and their roles in diseases. The UB/UBL system is truly remarkable in that it involves the physical linkage of entire pro- teins onto other proteins. With more than 1000 atoms, each UB and UBL is a relatively mas- sive modification that can profoundly affect the chemical and physical properties of its tar- gets. There is great diversity in the system, with more than a dozen different UBL in human cells. Furthermore, UB and some UBL become linked to each other in “chains” with different linkages defined by the amino acids connecting one UB (or UBL) and the next in the chain.
    [Show full text]